Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Imatinib Mesylate

U.S. FDA Requirements: Imatinib Mesylate

Pharmaceutical / Drug Definition : Inhibits proliferation of Bcr-Abl tyrosine kinase, an abnormal chromosome protein found in most patients with chronic myeloid leukemia (CML). This inhibition suppresses tumor growth.

Registrar Corp assists Imatinib Mesylate companies with:

  • FDA Registration Imatinib Mesylate
  • FDA Listing Imatinib Mesylate
  • FDA Label Requirements and Exceptions Imatinib Mesylate
  • FDA Import Information Imatinib Mesylate
  • FDA Detentions Imatinib Mesylate (Imatinib Mesylate Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Imatinib Mesylate (Imatinib Mesylate Suppliers)
       - Processors Imatinib Mesylate
       - Repackers Imatinib Mesylate
       - Relabelers Imatinib Mesylate
       - Exporters Imatinib Mesylate
       - Importers Imatinib Mesylate
For more information about Imatinib Mesylate, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco